Register / Log In

E-cigarettes and the ob/gyn: Key safety information for prenatal counseling


 

Dr. Phelan is Professor, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque. She is also a member of the Contemporary OB/GYN Editorial Board.

Ms. Mahoney is Director, the Providers Partnership Project, American College of Obstetricians and Gynecologists, Washington, DC.

Neither author has a conflict of interest to disclose with respect to the content of this article.

 

 

Until very recently, the discussion of tobacco use with patients, especially pregnant patients, was straightforward: No use was the best use.

Counseling and patient support, stronger tobacco control laws, and other measures have resulted in a slow but steady decline in prenatal cigarette use (from 18.4% in 1990 to 12.3% in 2010).1 However, the emergence of novel nicotine delivery vehicles in the United States has complicated the tobacco control landscape. Table 1 outlines these novel products, which generally contain either tobacco-derived or synthetically produced nicotine and are not combusted.2-5 

The correct response to oligohydramnios and polyhydramnios hinges on timing, severity, and comorbidity.

Four experts discuss the guidelines from the College of American Pathologists regarding placental examination.

A bowel injury during salpingectomy leads to septic shock and amputation. What went wrong?

Institutions around the country have responded to an FDA advisory by discouraging or banning power morcellation of uterine fibroids. Innovative methods of contained morcellation are now called for.

The latest data on optimal timing of umbilical cord clamping, risks for maternal morbidity, and situations in which risks outweigh potential benefits.